Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-30.62	34.14	49.21
Graham Fair Price	79.91	0.60	0.33
PEG	-82.25	0.07	-0.40
Price/Book	-1.59	3.49	3.54
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	-52.45	11.37	23.91
Price/Sales	33.97	1.51	1.12
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-5.96	0.11	0.12
Operating Margin	93.99	0.05	0.03
ROA	157.46	0.01	< 0.005
ROE	0.04	0.08	106.95
ROIC	0.02	0.02	25.56
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.05	-0.03	-92.39
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.45	0.84	85.22
EPS QOQ	-0.59	1.59	167.91
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	-0.10	-0.05	47.87
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.52	2.59	2.82
Days Sales Outstanding (DSO)	49.83	52.67	5.71
Inventory Turnover	35.76	34.78	-2.74
Debt/Capitalization	0.78	0.73	-6.43
Quick Ratio	1.08	0.87	-19.65
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	0.37	0.46	25.06
Cash	0.71	0.49	-30.93
Capex	n.A.	n.A.	n.A.
Free Cash Flow	n.A.	n.A.	n.A.
Revenue	1.16	1.06	-8.13
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.29	1.27	-1.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.36	11.12	-42.55
Naive Interpretation	Member

06 - Financial Health · Weak

Rating